Author:
Murphy Eleanor,Hou Liping,Maher Brion S,Woldehawariat Girma,Kassem Layla,Akula Nirmala,Laje Gonzalo,McMahon Francis J
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference44 articles.
1. Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F et al (2010). Integrating common and rare genetic variation in diverse human populations. Nature 467: 52–58.
2. Baldwin DS, Lopes ATV (2009). The influence of comorbid anxiety disorders on outcome in major depressive disorder. Medicographia 31: 126–130.
3. Brown C, Schulberg HC, Madonia MJ, Shear MK, Houck PR (1996). Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 153: 1293–1300.
4. Costello AB, Osborne JW (2005). Best practices in exploratory factor analysis: recommendations for getting the most from your analysis. Practical Assessment Res Eval 10: 1–9.
5. Cultler JA, Rush AJ, McMahon FJ, Laje G (2012). Common genetic variation in the indoleamine-2, 3-dioxigenase genes and antidpressant treatment outcome in major depressive disorder. J Psychopharmacol 26: 360–367.
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献